CoJourney Inc is an end-to-end global gene therapy Contract Development and Manufacturing Organisation (CDMO) that integrates a comprehensive range of services, including process development, cGMP manufacture, analytical methods development, and release testing for plasmids, viral vectors, and mRNA. With state-of-the-art facilities that adhere to FDA, EU, and NMPA guidelines, CoJourney operates a manufacturing facility in Hangzhou, China, alongside a dedicated process development lab in SpringHouse Innovation Park, Philadelphia, PA, USA. The company has developed the industry-leading Zero-Chrom Plasmid Platform, which eliminates the use of column chromatography, resulting in exceptional quality plasmids with higher yields than industry standards. CoJourney also leverages over 20 years of experience in AAV manufacturing to enhance its offerings.

Services include:
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Drug Product Formulation (FDF)
- Research & Development
- Clinical Trial Materials
- Packaging
- Regulatory Services
- Analytical Methods Development

CoJourney Inc remains committed to providing innovative and high-quality solutions to the pharmaceutical industry. For more information, please visit cojourney.com.